Selected article for: "CT scan and pneumonia patient"
Author: van Gorp, GAP; Sanders, PJLT; van Waardenburg, DA; Engel, Monique
Title: COVID-19 pneumonia successfully managed with high-flow nasal cannula in a 15-year-old boy
  • Cord-id: pmmtayxp
  • Document date: 2021_4_12
    • ID: pmmtayxp
    Snippet: We report an otherwise healthy, fully immunised 15-year-old boy who was transferred to our Pediatric intensive care unit with 4 days of fever, dry cough, increased work of breathing and impending respiratory failure. Two days prior, amoxicillin/clavulanic acid was prescribed for lower airway symptoms resembling pneumonia. PCR of the nasopharyngeal swab revealed an active COVID-19 infection (Ct 19). The CT scan showed significant ground-glass opacities highly associated with COVID-19 (COVID-19 re
    Document: We report an otherwise healthy, fully immunised 15-year-old boy who was transferred to our Pediatric intensive care unit with 4 days of fever, dry cough, increased work of breathing and impending respiratory failure. Two days prior, amoxicillin/clavulanic acid was prescribed for lower airway symptoms resembling pneumonia. PCR of the nasopharyngeal swab revealed an active COVID-19 infection (Ct 19). The CT scan showed significant ground-glass opacities highly associated with COVID-19 (COVID-19 reporting and data system 4). Antibiotics were continued and chloroquine was given for 5 days. High-flow nasal cannula (HFNC) was started as respiratory support therapy with rapid decrease of tachypnoea and oxygen demand. HFNC was successfully stopped after 7 days. The patient made full clinical recovery. This case illustrates HFNC as a successful respiratory support therapy in a paediatric patient with an active COVID-19 pneumonia.

    Search related documents:
    Co phrase search for related documents
    • absolute lymphocyte count and acute ards respiratory distress syndrome: 1, 2
    • absolute lymphocyte count and lung injury: 1, 2
    • absolute lymphocyte count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active infection and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • active infection and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • active infection and lupus rheumatoid arthritis: 1, 2
    • active infection and lymphocyte count: 1, 2, 3
    • acute ards respiratory distress syndrome and adequate personal protective equipment: 1, 2, 3
    • acute ards respiratory distress syndrome and liver enzyme: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and lung epithelium: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver enzyme and lung injury: 1
    • liver enzyme and lymphocyte count: 1, 2, 3, 4, 5, 6
    • lung injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11